Freda C Lewis-hall - Net Worth and Insider Trading
Freda C Lewis-hall Net Worth
The estimated net worth of Freda C Lewis-hall is at least $288 Million dollars as of 2024-11-13. Freda C Lewis-hall is the Director, 10% Owner of SpringWorks Therapeutics Inc and owns about 8,611,092 shares of SpringWorks Therapeutics Inc (SWTX) stock worth over $285 Million. Freda C Lewis-hall is also the Executive Vice President of Pfizer Inc and owns about 121,592 shares of Pfizer Inc (PFE) stock worth over $3 Million. Details can be seen in Freda C Lewis-hall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Freda C Lewis-hall has not made any transactions after 2019-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Freda C Lewis-hall
Freda C Lewis-hall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Freda C Lewis-hall owns 8 companies in total, including Exact Sciences Corp (EXAS) , SpringWorks Therapeutics Inc (SWTX) , and 1Life Healthcare Inc (ONEM) among others .
Click here to see the complete history of Freda C Lewis-hall’s form 4 insider trades.
Insider Ownership Summary of Freda C Lewis-hall
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EXAS | Exact Sciences Corp | 2020-04-22 | director |
SWTX | SpringWorks Therapeutics Inc | 2020-05-20 | director & 10 percent owner |
ONEM | 1Life Healthcare Inc | 2020-01-30 | director |
2013-09-16 | Senior Vice President | ||
2014-12-04 | director | ||
2008-06-18 | EVP & Medicines Development | ||
2021-10-07 | director | ||
2023-09-22 | director |
Freda C Lewis-hall Latest Holdings Summary
Freda C Lewis-hall currently owns a total of 2 stocks. Among these stocks, Freda C Lewis-hall owns 8,611,092 shares of SpringWorks Therapeutics Inc (SWTX) as of September 17, 2019, with a value of $285 Million and a weighting of 98.89%. Freda C Lewis-hall also owns 121,592 shares of Pfizer Inc (PFE) as of September 16, 2013, with a value of $3 Million and a weighting of 1.11%.
Latest Holdings of Freda C Lewis-hall
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SWTX | SpringWorks Therapeutics Inc | 2019-09-17 | 8,611,092 | 33.08 | 284,854,923 |
PFE | Pfizer Inc | 2013-09-16 | 121,592 | 26.19 | 3,184,494 |
Holding Weightings of Freda C Lewis-hall
Freda C Lewis-hall Form 4 Trading Tracker
According to the SEC Form 4 filings, Freda C Lewis-hall has made a total of 0 transactions in SpringWorks Therapeutics Inc (SWTX) over the past 5 years. The most-recent trade in SpringWorks Therapeutics Inc is the acquisition of 50,000 shares on September 17, 2019, which cost Freda C Lewis-hall around $900,000.
According to the SEC Form 4 filings, Freda C Lewis-hall has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 38,461 shares on September 16, 2013, which brought Freda C Lewis-hall around $1 Million.
Insider Trading History of Freda C Lewis-hall
- 1
Freda C Lewis-hall Trading Performance
GuruFocus tracks the stock performance after each of Freda C Lewis-hall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Freda C Lewis-hall is 28.57%. GuruFocus also compares Freda C Lewis-hall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Freda C Lewis-hall within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Freda C Lewis-hall's insider trading performs compared to the benchmark.
Performance of Freda C Lewis-hall
Freda C Lewis-hall Ownership Network
Ownership Network List of Freda C Lewis-hall
Ownership Network Relation of Freda C Lewis-hall
Freda C Lewis-hall Owned Company Details
What does Exact Sciences Corp do?
Who are the key executives at Exact Sciences Corp?
Freda C Lewis-hall is the director of Exact Sciences Corp. Other key executives at Exact Sciences Corp include Gen. Mgr. & Precision Oncology Brian Baranick , General Counsel James Herriott , and director & Vice President Kevin T Conroy .
Exact Sciences Corp (EXAS) Insider Trades Summary
Over the past 18 months, Freda C Lewis-hall made no insider transaction in Exact Sciences Corp (EXAS). Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 20,284 shares made by Sarah Condella , a net sale of 11,459 shares made by Brian Baranick , and a net sale of 5,403 shares made by James Herriott .
In summary, during the past 3 months, insiders sold 1,858 shares of Exact Sciences Corp (EXAS) in total and bought 0 shares, with a net sale of 1,858 shares. During the past 18 months, 170,352 shares of Exact Sciences Corp (EXAS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 170,352 shares.
Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exact Sciences Corp Insider Transactions
Freda C Lewis-hall Mailing Address
Above is the net worth, insider trading, and ownership report for Freda C Lewis-hall. You might contact Freda C Lewis-hall via mailing address: C/o Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge Ma 02139.